We are live on ! Find out more
CNAM

Campbell Newman Asset Management Portfolio holdings

AUM $1.35B
1-Year Est. Return 38.87%
This Fund
S&P 500
This Quarter Est. Return
+2.14%
1 Year Est. Return
+38.87%
3 Year Est. Return
+107.92%
5 Year Est. Return
+146.05%
10 Year Est. Return
+543.08%
AUM
$647M
AUM Growth
+$44.5M
Cap. Flow
+$36.8M
Cap. Flow %
5.69%
Top 10 Hldgs %
38.37%
Holding
132
New
4
Increased
65
Reduced
28
Closed
4

Top Buys

Rank Stock Value
1
TFC icon
Truist Financial
TFC
+$5.9M
2
CSCO icon
Cisco
CSCO
+$1.94M
3
JPM icon
JPMorgan Chase
JPM
+$1.79M
4
AAPL icon
Apple
AAPL
+$1.71M
5
TXN icon
Texas Instruments
TXN
+$1.66M

Sector Composition

Rank Sector Weight
1 Technology 28.09%
2 Financials 18.65%
3 Healthcare 15.1%
4 Consumer Discretionary 9.61%
5 Industrials 9.09%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
META icon
51
Meta Platforms (Facebook)
META
$1.51T
$1.56M 0.24%
8,007
-230
-3% -$41.6K
PFE icon
52
Pfizer
PFE
$153B
$1.55M 0.24%
45,017
WFC icon
53
Wells Fargo
WFC
$264B
$1.49M 0.23%
26,942
-132
-0.5% -$7.07K
KO icon
54
Coca-Cola
KO
$375B
$1.41M 0.22%
32,101
NSC icon
55
Norfolk Southern
NSC
$75.1B
$1.38M 0.21%
9,165
MRK icon
56
Merck
MRK
$318B
$1.18M 0.18%
20,446
BA icon
57
Boeing
BA
$185B
$1.15M 0.18%
3,416
-100
-3% -$34.4K
DD icon
58
DuPont de Nemours
DD
$19.2B
$1.14M 0.18%
6,812
USB icon
59
US Bancorp
USB
$99.6B
$1.07M 0.17%
21,446
-498
-2% -$25.3K
TJX icon
60
TJX Companies
TJX
$178B
$1.07M 0.16%
22,406
-1,396
-6% -$61.3K
IWR icon
61
iShares Russell Mid-Cap ETF
IWR
$57.4B
$1.03M 0.16%
19,444
TMO icon
62
Thermo Fisher Scientific
TMO
$220B
$1.01M 0.16%
4,868
-108
-2% -$22.9K
FDX icon
63
FedEx
FDX
$75.4B
$930K 0.14%
4,096
-263
-6% -$65.1K
FIVE icon
64
Five Below
FIVE
$13.5B
$923K 0.14%
9,451
+434
+5% +$34.9K
SBUX icon
65
Starbucks
SBUX
$120B
$883K 0.14%
18,076
-593
-3% -$33.7K
HSY icon
66
Hershey
HSY
$36.6B
$875K 0.14%
9,400
BRK.A icon
67
Berkshire Hathaway Class A
BRK.A
$1.12T
$846K 0.13%
3
FCB
68
DELISTED
FCB Financial Holdings, Inc.
FCB
$833K 0.13%
14,173
+650
+5% +$38.2K
SUPN icon
69
Supernus Pharmaceuticals
SUPN
$2.77B
$823K 0.13%
13,751
+633
+5% +$32.8K
CL icon
70
Colgate-Palmolive
CL
$74.4B
$818K 0.13%
12,626
-895
-7% -$58.5K
LGND icon
71
Ligand Pharmaceuticals
LGND
$6.36B
$791K 0.12%
6,117
+263
+4% +$29.3K
CVX icon
72
Chevron
CVX
$366B
$785K 0.12%
6,211
MTZ icon
73
MasTec
MTZ
$21.9B
$757K 0.12%
14,911
+684
+5% +$33K
TROW icon
74
T. Rowe Price
TROW
$24.3B
$755K 0.12%
6,500
AVGO icon
75
Broadcom
AVGO
$2.04T
$742K 0.11%
30,560
-1,560
-5% -$38.2K

Similar funds

Campbell Newman Asset Management's Q2 2018 Portfolio in Review

As of Q2 2018, Campbell Newman Asset Management held 132 positions worth $647M, up 7.4% from $602M the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Campbell Newman Asset Management deployed $36.8M of net new capital in Q2 2018, opening 4 new positions and adding to 65 existing holdings. Its largest new stake was Moelis & Co: 7,766 shares worth $455K.

By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 27% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Travelers Companies, an estimated $4.49M trimmed.

  • Campbell Newman Asset Management's largest Q2 2018 buy was Moelis & Co: 7,766 shares worth $455K.
  • Campbell Newman Asset Management added most to Truist Financial in Q2 2018, an estimated $5.9M increase.
  • Campbell Newman Asset Management's biggest Q2 2018 reduction was Travelers Companies, cutting an estimated $4.49M.
  • Campbell Newman Asset Management fully exited Allergan plc in Q2 2018, selling an estimated $424K.
  • Campbell Newman Asset Management's ten largest holdings make up 38% of its $647M portfolio in Q2 2018.
  • Campbell Newman Asset Management opened 4 new positions and closed 4 in Q2 2018.
  • Campbell Newman Asset Management's portfolio value rose 7.4% quarter-over-quarter to $647M.

Based on Campbell Newman Asset Management's 13F filing for Q2 2018, filed 25 Jul 2018.